Risk Factors for Carbapenem-Resistant Organisms Pneumonia in the Pediatric and Neonatal Intensive Care Units: A Study at Dr.Kariadi Hospital
Sebuah studi di RSUP Dr. Kariadi
DOI:
https://doi.org/10.36408/mhjcm.v13i1.1353Keywords:
Antimicrobial resistance, Carbapenem-Resistant Organisms, Intensive Care Unit, pediatrics, pneumoniaAbstract
BACKGROUND: Inappropriate antibiotic use has led to bacterial resistance, including carbapenem-resistant organisms (CROs), which cause severe infections in neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) patients. CRO infections are associated with high morbidity and mortality rates, with limited treatment options. Risk factors such as prolonged hospitalization, broad-spectrum antibiotic use, invasive procedures, and prior infections contribute to these cases. This study is the first in Indonesia to specifically examine CRO pneumonia risk factors in NICU and PICU children.
OBJECTIVES: This study aimed to analyze the risk factors for pneumonia caused by carbapenem-resistant organisms (CROs) in children in the pediatric and neonatal intensive care unit.
METHODS: This case-control study was conducted in neonatal intensive care unit (NICU) and Pediatric Intensive Care Unit (PICU) of Dr. Kariadi Hospital, Semarang, using medical records of patients admitted between November 2022 and October 2024. This study analyzed the relationship between various risk factors, including hospitalization duration, antibiotic use, mechanical ventilation, catheterization, prior surgery, and bacterial infection history, with CRO pneumonia in NICU and PICU patients.
RESULTS: This case-control study in NICU and PICU on 87 pediatric pneumonia patients found that 55.2% had CRO pneumonia. Multivariate analysis revealed that carbapenem use for >7 days (p = 0.049), mechanical ventilation (p = 0.044), and urinary catheterization (p = 0.020) were independent risk factors for CRO pneumonia.
CONCLUSION: CRO infections in NICU and PICU patients are highly prevalent, with prolonged carbapenem use, mechanical ventilation, and urinary catheterization as independent risk factors for CRO pneumonia.
Downloads
References
1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harris, et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clinical Infectious Diseases. 2011 Oct 1;53(7):e25–76. doi:10.1093/cid/cir531
2. Assefa M. Multi-drug resistant gram-negative bacterial pneumonia: Etiology, risk factors, and drug resistance patterns. Pneumonia. 2022 May 5;14(1):4. doi:10.1186/s41479-022-00096-z
3. Zhang Y, Xu G, Miao F, Huang W, Wang H, Wang X. Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children. Front Public Health. 2023 Nov 30;11. doi:10.3389/fpubh.2023.1282413
4. Tuon FF, Graf ME, Merlini A, Rocha JL, Stallbaum S, Arend LN, et al. Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant enterobacteriaceae. The Brazilian Journal of Infectious Diseases. 2017 Jan;21(1):1–6. doi:10.1016/j.bjid.2016.09.008
5. Alnimr A. Antimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy. Infect Dis Ther. 2023 Jun 5;12(6):1527–52. doi:10.1007/s40121-023-00820-2
6. Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, et al. Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant enterobacteriaceae. Front Pharmacol. 2019 Mar 22;10. doi:10.3389/fphar.2019.00262
7. Zhang Y, Guo LY, Song WQ, Wang Y, Dong F, Liu G. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients. BMC Infect Dis. 2018 Dec 31;18(1):248. doi:10.1186/s12879-018-3160-3
8. Yen CS, Hsiao HL, Lee CC, Tsai TC, Chen HY, Chen CL, et al. Carbapenem-resistant Enterobacteriaceae infection in children less than one year old in an Asian medical center. Pediatr Neonatol. 2023 Mar;64(2):168–75. doi:10.1016/j.pedneo.2022.05.016
9. Lou T, Du X, Zhang P, Shi Q, Han X, Lan P, et al. Risk factors for infection and mortality caused by carbapenem-resistant klebsiella pneumoniae: A large multicentre case–control and cohort study. Journal of Infection. 2022 May;84(5):637–47. doi:10.1016/j.jinf.2022.03.010
10. Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, et al. Risk factors for infections caused by carbapenem-resistant enterobacterales: An international matched case-control-control study (EURECA). EClinicalMedicine. 2023 Mar;57:101871. doi:10.1016/j.eclinm.2023.101871
11. Cienfuegos-Gallet A V, Ocampo de Los Ríos AM, Sierra Viana P, Ramirez Brinez F, Restrepo Castro C, Roncancio Villamil G, et al. Risk factors and survival of patients infected with carbapenem-resistant klebsiella pneumoniae in a KPC endemic setting: A case-control and cohort study. BMC Infect Dis. 2019 Dec 7;19(1):830. doi:10.1186/s12879-019-4461-x
12. Meng H, Yang J, Niu M, Zhu H, Zhou Y, Lu J. Risk factors and clinical outcomes of carbapenem-resistant klebsiella pneumoniae bacteraemia in children: A retrospective study. Int J Antimicrob Agents. 2023 Oct;62(4):106933. doi:10.1016/j.ijantimicag.2023.106933
13. Hegazy EE, Bahey MG, Abo Hagar AM, Elkholy AA, Mohamed EA. Carbapenem-resistant gram-negative bacilli causing ventilator associated pneumonia: Study of mastdiscs combi carba plus for detection of carbapenemase producing enterobacterales. Infect Drug Resist. 2022 Oct;Volume 15:6331–42. doi:10.2147/IDR.S385294
14. Li J, Li Y, Song N, Chen Y. Risk factors for carbapenem-resistant klebsiella pneumoniae infection: A meta-analysis. J Glob Antimicrob Resist. 2020 Jun;21:306–13. doi:10.1016/j.jgar.2019.09.006
15. Maltezou HC, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M. Infections caused by carbapenem-resistant gram-negative pathogens in hospitalized children. Pediatric Infectious Disease Journal. 2013 Apr;32(4):e151–4. doi:10.1097/INF.0b013e3182804b49
16. Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, et al. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome. Diagn Microbiol Infect Dis. 2017 Apr;87(4):359–64. doi:10.1016/j.diagmicrobio.2016.12.013
17. Chuah CH, Gani Y, Sim B, Chidambaram SK. Risk factors of carbapenem-resistant enterobacteriaceae infection and colonisation: A malaysian tertiary care hospital based case-control study. Journal of the Royal College of Physicians of Edinburgh. 2021 Mar 1;51(1):24–30. doi:10.4997/jrcpe.2021.107
18. Wijayanti L, Sianipar O, Dewi A. Lama perawatan lebih dari tujuh hari sebagai faktor risiko infeksi carbapenem resistant enterobacteriaceae. UGM Press. 2015.
19. Liang Y, Zhao C, Lu Y, Liao K, Kong Y, Hong M, et al. Microbiological characteristics, risk factors, and short-term mortality of carbapenem-resistant enterobacteriaceae bloodstream infections in pediatric patients in China: A 10-year longitudinal study. Infect Drug Resist. 2024 Nov;Volume 17:4815–23. doi:10.2147/IDR.S485001
20. Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar M V, Bilker WB, et al. Multicenter study of the risk factors for colonization or infection with carbapenem-resistant enterobacteriaceae in children. Antimicrob Agents Chemother. 2017 Dec;61(12). doi:10.1128/AAC.01440-17 PubMed PMID: 28971864.
21. El-Nawawy A, Ashraf GA, Antonios MAM, Meheissen MA, El-Alfy MMR. Incidence of multidrug-resistant organism among children admitted to pediatric intensive care unit in a developing country. Microbial Drug Resistance. 2018 Oct 1;24(8):1198–206. doi:10.1089/mdr.2017.0414 PubMed PMID: 29589993.
22. Widyawati N, Setiabudi RJ, Hamat MHBC. Prevalence and incidence antimicrobial resistance of patients pneumonia in Indonesia: Systematic review and meta-analysis. Biomolecular and Health Science Journal. 2025 Jan;8(1):66–77. doi:10.4103/bhsj.bhsj_47_24
23. Amalia TR, Halimah E, Adrizain R, Khairinisa MA. Carbapenems: A literature review regarding resistance, risk factors, and mortality in pneumonia. Pharmacology and Clinical Pharmacy Research. 2021;6(1):35–52. doi:10.15416/pcpr.v4i3.32282
24. Wang Z, Qin RR, Huang L, Sun LY. Risk factors for carbapenem-resistant klebsiella pneumoniae infection and mortality of klebsiella pneumoniae infection. Chin Med J (Engl). 2018 Jan 5;131(1):56–62. doi:10.4103/0366-6999.221267
25. Cai S, Wang Z, Han X, Hu H, Quan J, Jiang Y, et al. The correlation between intestinal colonization and infection of carbapenem-resistant Klebsiella pneumoniae: A systematic review. J Glob Antimicrob Resist. 2024 Sep;38:187–93. doi:10.1016/j.jgar.2024.04.013
26. Espitia-Acero C, García-Betancur JC, Cadena ED La, Pallares CJ, Restrepo-Arbeláez N, Patiño-Guevara E, et al. Colonization status and risk factors for infection by carbapenem-resistant gram-negative bacteria in intensive care units (ICU) in Colombia. Journal of Hospital Infection. 2025 Nov. doi:10.1016/j.jhin.2025.11.003
27. Karki S, Fitzpatrick A, Shrestha S. Risk factors for pneumonia in children under 5 years in a teaching hospital in Nepal. Kathmandu University Medical Journal. 2015 Oct 19;12(4):247–52. doi:10.3126/kumj.v12i4.13729
28. Al-Dalfi MHK, Al Ibraheem SAH, Al-Rubaye AKQ. The severity of pneumonia and its association with socio-demographic factors among children under five years old in Wasit governorate hospitals, Iraq. J Public Health Afr. 2023 Aug 1;14(8). doi:10.4081/jphia.2023.2674
29. Fadl N, Ashour A, Yousry Muhammad Y. Pneumonia among under-five children in Alexandria, Egypt: A case-control study. Journal of the Egyptian Public Health Association. 2020 Dec 1;95(1):14. doi:10.1186/s42506-020-00043-0
30. Pimtimanon N, Assawawiroonhakarn S, Boonsathorn S. Carbapenem-resistant gram-negative bacteria colonization in immunocompromised and critically ill pediatric patients: prevalence, risk factors, and outcomes. Sage Open Pediatrics. 2025 Feb 22;12. doi:10.1177/30502225251366351
31. Oktafia P, Prananda Surya Airlangga, Ira D, Retno AS. Risk factors of complicated pneumonia in children. Journal of the Indonesian Medical Association. 2021 Jul 23;71(3):135–40. doi:10.47830/jinma-vol.71.3-2021-336
32. Wexler ID, Knoll S, Picard E, Villa Y, Shoseyov D, Engelhard D, et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol. 2006 Aug;41(8):726–34. doi:10.1002/ppul.20383
33. Primaningtyas W, Pamungkasari EP, - S. Factors causing acinetobacter baumannii resistance to carbapenem antibiotics in patients with healthcare associated infection (HCAI) at Dr. Moewardi Hospital, Surakarta. Indonesian Journal of Medicine. 2017;02(02):125–38. doi:10.26911/theijmed.2017.02.02.07
34. Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: A retrospective study. Pathog Glob Health. 2015 Mar 30;109(2):68–74. doi:10.1179/2047773215Y.0000000004
35. Li YY, Chen Y, Li S, Li YY, An R, Hu XY, et al. Impact of Immunosuppressed Status on prognosis of carbapenem-resistant organisms bloodstream infections. Infect Dis Ther. 2024 Apr 27;13(4):861–74. doi:10.1007/s40121-024-00956-9
36. Zhang D, Cui K, Wang T, Shan Y, Dong H, Feng W, et al. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital. The Journal of Infection in Developing Countries. 2018 Aug 31;12(08):642–8. doi:10.3855/jidc.10150
37. Duhaniuc A, Sima CM, Buruiană G, Luncă C, Dorneanu OS. Antibiotic resistance patterns of bacteria involved in colonization and/or infection of patients in intensive care units in Northeastern Romania. Antibiotics. 2025 Oct 23;14(11):1063. doi:10.3390/antibiotics14111063
38. Liu X, Sai F, Li L, Zhu C, Huang H. Clinical characteristics and risk factors of catheter-associated urinary tract infections caused by klebsiella pneumoniae. Ann Palliat Med. 2020 Sep;9(5):2668–77. doi:10.21037/apm-20-1052
39. Liu Y, Xu Y, Wang S, Zeng Z, Li Z, Din Y, et al. Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia. Heliyon. 2023 May;9(5):e15724. doi:10.1016/j.heliyon.2023.e15724
40. Peghin M, Givone F, de Martino M, Ali RW, Graziano E, Isola M, et al. Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization. European Journal of Clinical Microbiology & Infectious Diseases. 2024 Nov 16;43(11):2191–9. doi:10.1007/s10096-024-04936-2
41. Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review. J Appl Microbiol. 2021 Dec 21;131(6):2715–38. doi:10.1111/jam.15130
42. Quarata F, Lelli D, Biancone DM, Gherardi G, Incalzi RA. A urinary tract infection caused by Escherichia coli mucoid phenotype progresses to a pneumonia and respiratory failure. The Lancet. 2023 Mar;401(10380):950. doi:10.1016/S0140-6736(23)00224-6
43. Haider MZ, Annamaraju P. Bladder Catheterization. 2025. PubMed PMID: 32809583.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2026 Nahwa Arkhaesi, Yusrina Istanti, Mohammad Supriatna Toto Saputra, Dewi Ratih Priyatiningsih, Indah Soleha, Salma Tyas Salsabila (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
